BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3890789)

  • 1. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients.
    Fainstein V; Bodey GP; Bolivar R; Elting L; McCredie KB; Keating MJ
    Arch Intern Med; 1984 Sep; 144(9):1766-70. PubMed ID: 6383246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.
    Jones P; Rolston K; Fainstein V; Elting L; Bodey GP
    Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in endogenous microflora among febrile granulocytopenic patients receiving empiric antibiotic therapy: implications for fungal superinfection.
    Bow EJ; Louie TJ
    CMAJ; 1987 Sep; 137(5):397-403. PubMed ID: 3304600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
    Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized trial of empirical antibiotic therapy in febrile episodes after bone marrow transplantation. Comparison of an aminoglycoside-beta lactam (tobramycin-ticarcillin) combination with 2 beta-lactam antibiotics (ticarcillin-latamoxef)].
    Viens P; Maraninchi D; Gaspard MH; Stoppa AM; Blaise D; Miquel M; Mannoni P; Carcassonne Y
    Pathol Biol (Paris); 1988 May; 36(5):567-70. PubMed ID: 3043359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
    Jansen W; Schwarz A
    Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes.
    Riben PD; Horsman GB; Rayner E; Irvine-Meek J; Urias B; Albritton WL; deSaxe MJ; Ronald AR; Louie TJ
    Clin Invest Med; 1985; 8(4):272-85. PubMed ID: 3907919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study of tobramycin plus ticarcillin, tobramycin plus cephalothin and ticarcillin, or tobramycin plus mezlocillin in the treatment of infection in neutropenic patients with malignancies.
    Lawson RD; Gentry LO; Bodey GP; Keating MJ; Smith TL
    Am J Med Sci; 1984; 287(1):16-23. PubMed ID: 6367466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutropenia associated with beta-lactam antibiotics.
    Kirkwood CF; Smith LL; Rustagi PK; Schentag JJ
    Clin Pharm; 1983; 2(6):569-78. PubMed ID: 6653059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
    Gucalp R; Lia S; McKitrick JC; Wiernik PH
    Am J Med; 1988 Jul; 85(1A):31-5. PubMed ID: 3041816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
    Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
    Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
    Elliott CR; Pater JL
    Clin Invest Med; 1988 Oct; 11(5):327-30. PubMed ID: 3141096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.